Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics

The use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarri...

Full description

Saved in:
Bibliographic Details
Published inJournal of drug targeting Vol. 27; no. 7; pp. 732 - 741
Main Authors de Sousa Cunha, Fabiana, dos Santos Pereira, Laise Nayra, de Costa e Silva, Thâmara Pryscilla, de Sousa Luz, Roberto Alves, Nogueira Mendes, Anderson
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 09.08.2019
Subjects
breast cancer
nanocarriers
Nanomedicine
ovarian cancer
theranostics
breast cancer
theranostics
ovarian cancer
Nanomedicine
nanocarriers
Online AccessGet full text

Cover

More Information
Summary:The use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers, which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the present work is a review that examines some nanosystems with nanoparticles for action in the treatment of breast cancer and ovarian cancer.
ISSN:1061-186X
1029-2330
DOI:10.1080/1061186X.2018.1523418